环丙基甲基酮的合成研究进展

环丙基甲基酮是合成环丙氟哌酸类广谱抗菌药物和抗艾滋特效药依法韦仑的重要中间体,在医药、化工及农林等领域均有广泛应用。环丙基甲基酮的合成方法大致分为4类,分别以酮类、酯类、醇类及呋喃有机物为原料,在一定条件下生成环丙基甲基酮粗品,经萃取及精馏得到环丙基甲基酮纯品。本文综述了环丙基甲基酮的合成研究进展。     

减肥食品中违禁药物芬氟拉明、安非拉酮、马吲哚的气相色谱-质谱检测

建立了减肥食品中违禁药物芬氟拉明、安非拉酮和马吲哚的定性和定量分析方法。样品用氯仿提取, HP-5MS毛细管色谱柱分离,扫描方式(scan)定性确证,选择离子方式(SIM)定量。结果表明,减肥食品中芬氟拉明、安非拉酮、马吲哚能在气相色谱-质谱联用仪上同时得到分析,与NIST98谱库比较,匹配度均在90％以上,说明该方法适用于减肥食品中这3种药物的确证分析和定量分析。     

Flow Injection Chemiluminescence Sensor with Novel Rhodanine Ramification for Determination of Fenfluramine Based on Molecularly Imprinted Polymer

Abstract

Flow injection chemiluminescence (FI-CL) with molecularly imprinted polymer (MIP) was applied to determine fenfluramine. The fenfluramine-imprinted polymer was prepared with acrylamide (AM) as functional monomer and ethylene glycol dimethacrylate (EGDMA) as cross-linker. Methyl and sulfonic group were introduced to rhodanine matrix, and a novel rhodanine ramification 3MORASP was synthesized by the author, and it was used as chemiluminescence reagent. 3-(3′-Methoxyphenyl)-5(2′-sulfonylphenylazo)-rhodanine (3MORASP), first synthesized by the authors, was used as chemiluminescence (CL) reagent. The novel flow path of FI-CL was designed, which made three merged streams of reactants injected into MIP column move through different pathways simultaneously. Fenfluramine was detected based on the reaction of fenfluramine, 3MORASP, and potassium permanganate in an acidic medium. The CL intensity was correlated linearly with the concentration of fenfluramine over the range of 1.0 × 10^?7 to 5.0 × 10^?6 g · mL^?1, and the detection limit was 9.48 × 10^?9 g · mL^?1. The relative standard deviation (RSD) was 2.4% for determination of 1.0 × 10^?6 g · mL^?1 fenfluramine (n = 11). This method was successfully applied to the determination of fenfluramine in weight-reducing tonic.     

Quantitative 1H NMR method for the routine spectroscopic determination of enantiomeric purity of active pharmaceutical ingredients fenfluramine, sertraline, and paroxetine

Determining the enantiomeric purity of chiral therapeutic agents is important in the development of active pharmaceutical ingredients (API). A strategy for determining the enantiomeric purity of three APIs was developed using nuclear magnetic resonance (NMR) and the chiral solvating agent (CSA) 1,1-bi-2-naphthyl (1). While chiral chromatography is widely used to evaluate enantiomeric purity, it can sometimes suffer from tedious sample preparation obviating rapid measurements that are sometimes needed during the manufacture of such agents. The techniques described herein provide comparable enantiomeric purity results with those obtained with traditional chiral HPLC and other published methods for these compounds. Chiral analysis of standard samples of methylbenzylamine enantiomeric mixtures using 1 were found to be quantitative to approximately 1% minor enantiomer. Enantiomeric purity determination by NMR utilizing chiral solvating agents do not require special instrumental techniques, chemical derivatization or standards and is therefore ideally suited for rapid routine analysis. As a result, the technique demonstrated is commonly used in our laboratory as a complementary or alternative method to chiral HPLC or optical rotation measurements for routine determination of enantiomeric purity.     

衍生化气相色谱法测定盐酸芬氟拉明片的纯度

 应用衍生化气相色谱法测定盐酸芬氟拉明片的纯度。样品溶解后经碱化乙酸乙酯提取 ,以盐酸美西律作内标 ,提取液用三氟乙酸酐进行酰化衍生化 ,衍生化产物在 5 %SE 30的色谱柱上分析 ,用氢火焰离子化检测器 (FID)检测。实验结果表明 ,芬氟拉明的质量浓度在 0 1g/L～ 0 5 g/L范围内线性良好 (r =0 9996 ) ;芬氟拉明与内标美西律的分离度大于 4;理论塔板数以芬氟拉明峰计大于 2 0 0 0 ;方法的精密度好 ,相对标准偏差 (RSD)为 1 4% (n=7) ;平均回收率为 (10 0 2± 2 2 ) % (n =6 ) ;检测限为 8ng。用该方法得到的结果灵敏、准确、重复性好。     

柱前衍生高效液相色谱法测定减肥药中的芬氟拉明

建立了柱前衍生反相高效液相色谱—紫外检测方法用于测定减肥药中的芬氟拉明。样品用三氯甲烷萃取,异丙醇转溶,再在四氢呋喃中和60℃下,用苯异氰酸酯衍生35min,然后用甲醇／水(72／28,V／V)为流动相和Kromasil C18分离柱,在240nm检测衍生物。方法的线性范围在2．52—126mg／L(r=0．9994),检出限和定量限分别为0．36ng(S／N=3)和1．2ng(S／N=10),平均回收率为98．4％,相对标准偏差(RSD)小于3．00％。     

硝基氟苯柱前衍生HPLC测定减肥药中芬氟拉明

诺贝尔奖获得者F．sange使用2,4-二硝基氟苯(DNFB)确定了蛋白质中氨基酸排列次序以来,DNFB常用作为胺类化合物的衍生试剂。在碱性溶液中,DNFB与胺反应生成强紫外吸收的硝基苯胺类化合物。芬氟拉明(Fenfluramine,FFA)化学名为N-乙基-α-甲基-3-三氟甲基苯乙胺,属苯乙胺类食欲抑制剂,对人体健康有潜在危害。HPLC分析FFA的报道,检测限仅为20．6ng。本文用DNFB为衍生试剂,研究衍生化条件,色谱分析检测限降至1．02ng。